BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38547770)

  • 1. Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1β and modulating immunosuppressive response in OSCC.
    Mahale A; Routholla G; Lavanya S; Sharma P; Ghosh B; Kulkarni OP
    Int Immunopharmacol; 2024 May; 132():111921. PubMed ID: 38547770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1β secretion in diabetic mice.
    Karnam K; Sedmaki K; Sharma P; Routholla G; Goli S; Ghosh B; Venuganti VVK; Kulkarni OP
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165903. PubMed ID: 32712153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
    Gold WA; Lacina TA; Cantrill LC; Christodoulou J
    J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein attenuates LPS
    Zhou S; Huang J; Li K; DU S; Yang B; Guo Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):707-716. PubMed ID: 35837770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
    Yu J; Ma Z; Shetty S; Ma M; Fu J
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation.
    Chi Z; Byeon HE; Seo E; Nguyen QT; Lee W; Jeong Y; Choi J; Pandey D; Berkowitz DE; Kim JH; Lee SY
    Pharmacol Res; 2019 Aug; 146():104281. PubMed ID: 31125601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
    Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
    Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC6 inhibition attenuates renal injury by reducing IL-1β secretion and RIP kinase mediated necroptosis in acute oxalate nephropathy.
    Sedmaki K; Karnam K; Sharma P; Mahale A; Routholla G; Ghosh B; Prakash Kulkarni O
    Int Immunopharmacol; 2022 Sep; 110():108919. PubMed ID: 35717839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
    Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
    Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of histone deacetylase reduces lipopolysaccharide-induced-inflammation in primary mammary epithelial cells by regulating ROS-NF-кB signaling pathways.
    Wang J; Zhao L; Wei Z; Zhang X; Wang Y; Li F; Fu Y; Liu B
    Int Immunopharmacol; 2018 Mar; 56():230-234. PubMed ID: 29414656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
    Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
    J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
    Asthana J; Kapoor S; Mohan R; Panda D
    J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury.
    Liu L; Zhou X; Shetty S; Hou G; Wang Q; Fu J
    Toxicol Appl Pharmacol; 2019 May; 370():178-183. PubMed ID: 30910594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase 6 inhibition restores autophagic flux to promote functional recovery after spinal cord injury.
    Zheng Z; Zhou Y; Ye L; Lu Q; Zhang K; Zhang J; Xie L; Wu Y; Xu K; Zhang H; Xiao J
    Exp Neurol; 2020 Feb; 324():113138. PubMed ID: 31794745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90.
    Tao H; Chen YY; Sun ZW; Chen HL; Chen M
    J Cell Biochem; 2018 Aug; 119(8):6623-6632. PubMed ID: 29665050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HDAC6 by tubastatin A disrupts mouse oocyte meiosis via regulating histone modifications and mRNA expression.
    Sui L; Huang R; Yu H; Zhang S; Li Z
    J Cell Physiol; 2020 Oct; 235(10):7030-7042. PubMed ID: 32017059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β release.
    Bockstiegel J; Wurnig SL; Engelhardt J; Enns J; Hansen FK; Weindl G
    Biochem Pharmacol; 2023 Sep; 215():115693. PubMed ID: 37481141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation.
    Song R; Yang Y; Lei H; Wang G; Huang Y; Xue W; Wang Y; Yao L; Zhu Y
    J Mol Cell Cardiol; 2018 Nov; 124():58-69. PubMed ID: 30315806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.
    Maharaj K; Powers JJ; Mediavilla-Varela M; Achille A; Gamal W; Quayle S; Jones SS; Sahakian E; Pinilla-Ibarz J
    Front Immunol; 2020; 11():590072. PubMed ID: 33329575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma.
    Pang X; Fan HY; Tang YL; Wang SS; Cao MX; Wang HF; Dai LL; Wang K; Yu XH; Wu JB; Tang YJ; Liang XH
    PLoS One; 2020; 15(2):e0229089. PubMed ID: 32092078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.